Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation

Journal of Cardiovascular Electrophysiology

Volumn 20, Issue 2, 2009, Pages 207-215

  Van Brakel, Thomas J ^a   Hermans, J J Rob ^b   Accord, Ryan E ^a   Schotten, Ulrich ^b   Smits, Jos F M ^b   Allessie, Maurits A ^b   Maessen, Jos G ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Antiarrhythmic drugs; Atrial fibrillation; Epicardial; Intrapericardial

Indexed keywords

FLECAINIDE ACETATE; SOTALOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVERSION; CONTROLLED STUDY; DRUG TISSUE LEVEL; ELECTROCARDIOGRAM; ENDOCARDIUM; EPICARDIUM; GOAT; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE REFRACTORY PERIOD; HEART PACING; NONHUMAN; PRIORITY JOURNAL; ST SEGMENT ELEVATION;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ELECTRIC STIMULATION; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FLECAINIDE; GOATS; HEART ATRIA; INJECTIONS; INJECTIONS, INTRAVENOUS; PERICARDIUM; SOTALOL;

EID: 59149098613     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2008.01318.x     Document Type: Article

References (30)

1. Spodick DH : Macrophysiology, microphysiology, and anatomy of the pericardium: A synopsis. Am Heart J 1992 124 : 1046 1051.
2. Fei L, Baron AD, Henry DP, Zipes DP : Intrapericardial delivery of L-arginine reduces the increased severity of ventricular arrhythmias during sympathetic stimulation in dogs with acute coronary occlusion: Nitric oxide modulates sympathetic effects on ventricular electrophysiological properties. Circulation 1997 96 : 4044 4049.
3. Baek SH, Hrabie JA, Keefer LK, Hou D, Fineberg N, Rhoades R, March KL : Augmentation of intrapericardial nitric oxide level by a prolonged-release nitric oxide donor reduces luminal narrowing after porcine coronary angioplasty. Circulation 2002 105 : 2779 2784.
4. Ayers GM, Rho TH, Ben-David J, Besch HR Jr., Zipes DP : Amiodarone instilled into the canine pericardial sac migrates transmurally to produce electrophysiologic effects and suppress atrial fibrillation. J Cardiovasc Electrophysiol 1996 7 : 713 721.
5. Hermans JJ, van Essen H, Struijker-Boudier HA, Johnson RM, Theeuwes F, Smits JF : Pharmacokinetic advantage of intrapericardially applied substances in the rat. J Pharmacol Exp Ther 2002 301 : 672 678.
6. Fromes Y, Salmon A, Wang X, Collin H, Rouche A, Hagege A, Schwartz K, Fiszman MY : Gene delivery to the myocardium by intrapericardial injection. Gene Ther 1999 6 : 683 688.
7. Hou D, Zhang P, Marsh AE, March KL : Intrapericardial ethanol delivery inhibits neointimal proliferation after porcine coronary overstretch. J Chin Med Assoc 2003 66 : 637 642.
8. Laham RJ, Rezaee M, Post M, Novicki D, Sellke FW, Pearlman JD, Simons M, Hung D : Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia. J Pharmacol Exp Ther 2000 292 : 795 802.
9. Moreno R, Waxman S, Rowe K, Verrier RL : Intrapericardial beta-adrenergic blockade with esmolol exerts a potent antitachycardic effect without depressing contractility. J Cardiovasc Pharmacol 2000 36 : 722 727.
10. Ujhelyi MR, Hadsall KZ, Euler DE, Mehra R : Intrapericardial therapeutics: A pharmacodynamic and pharmacokinetic comparison between pericardial and intravenous procainamide delivery. J Cardiovasc Electrophysiol 2002 13 : 605 611.
11. van Brakel TJ, Hermans JJ, Janssen BJ, van Essen H, Botterhuis N, Smits JF, Maessen JG : Intrapericardial delivery enhances cardiac effects of sotalol and atenolol. J Cardiovasc Pharmacol 2004 44 : 50 56.
12. Vereckei A, Gorski JC, Ujhelyi M, Mehra R, Zipes DP : Intrapericardial ibutilide administration fails to terminate pacing-induced sustained atrial fibrillation in dogs. Cardiovasc Drugs Ther 2004 18 : 269 277.
13. Waxman S, Moreno R, Rowe KA, Verrier RL : Persistent primary coronary dilation induced by transatrial delivery of nitroglycerin into the pericardial space: A novel approach for local cardiac drug delivery. J Am Coll Cardiol 1999 33 : 2073 2077.
14. Darsinos JT, Karli JN, Samouilidou EC, Krumbholz B, Pistevos AC, Levis GM : Distribution of amiodarone in heart tissues following intrapericardial administration. Int J Clin Pharmacol Ther 1999 37 : 301 306.
15. Tieleman RG, Van Gelder IC, Bosker HA, Kingma T, Wilde AA, Kirchhof CJ, Bennekers JH, Bracke FA, Veeger NJ, Haaksma J, Allessie MA, Crijns HJ : Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation? Heart Rhythm 2005 2 : 223 230.
16. Nichol G, McAlister F, Pham B, Laupacis A, Shea B, Green M, Tang A, Wells G : Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation. Heart 2002 87 : 535 543.
17. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagne P, Nattel S, Thibault B : Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000 342 : 913 920.
18. Maintenance of sinus rhythm in patients with atrial fibrillation : An AFFIRM substudy of the first antiarrhythmic drug. J Am Coll Cardiol 2003 42 : 20 29.
19. Gleason JD, Nguyen KP, Kissinger KV, Manning WJ, Verrier RL : Myocardial drug distribution pattern following intrapericardial delivery: An MRI analysis. J Cardiovasc Magn Reson 2002 4 : 311 316.
20. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA : Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995 92 : 1954 1968.
21. Takiguchi Y, Ishihara R, Kato R, Kamihara S, Yokota M, Uematsu T : Measurement of flecainide in hair as an index of drug exposure. J Pharm Sci 2001 90 : 1891 1896.
22. Brugada P, Brugada J : Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: A multicenter report. J Am Coll Cardiol 1992 20 : 1391 1396.
23. Yan GX Antzelevitch : Cellular basis of the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 1999 100 : 1660 1666.
24. Fish JM, Antzelevitch C : Role of sodium and calcium channel block in unmasking the Brugada syndrome. Heart Rhythm 2004 1 : 210 217.
25. Fynn SP, Todd DM, Hobbs WJ, Armstrong KL, Garratt CJ : Role of dispersion of atrial refractoriness in the recurrence of clinical atrial fibrillation; A manifestation of atrial electrical remodelling in humans? Eur Heart J 2001 22 : 1822 1834.
26. Blaauw Y, Gogelein H, Tieleman RG, van Hunnik A, Schotten U, Allessie MA : "Early" class III drugs for the treatment of atrial fibrillation: Efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat. Circulation 2004 110 : 1717 1724.
27. Tse HF, Lau CP : Electrophysiologic actions of dl-sotalol in patients with persistent atrial fibrillation. J Am Coll Cardiol 2002 40 : 2150 2155.
28. Wijffels MC, Dorland R, Allessie MA : Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: A comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol. J Cardiovasc Electrophysiol 1999 10 : 178 193.
29. Schuessler RB, Kawamoto T, Hand DE, Mitsuno M, Bromberg BI, Cox JL, Boineau JP : Simultaneous epicardial and endocardial activation sequence mapping in the isolated canine right atrium. Circulation 1993 88 : 250 263.
30. Houben RP, de Groot NM, Smeets JL, Becker AE, Lindemans FW, Allessie MA : Swave predominance of epicardial electrograms during atrial fibrillation in humans: Indirect evidence for a role of the thin subepicardial layer. Heart Rhythm 2004 1 : 639 647.